| Inflammatory cytokines and oral lichen planus: a Mendelian randomization study. | Inflammatory cytokines and oral lichen planus: a Mendelian randomization study.
Chen X, Zhang S, Wu X, Lei Y, Lei B, Zhao Z., Free PMC Article | 03/25/2024 |
| Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA. | Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA.
Shi K, Zhou J, Li M, Yan W, Zhang J, Zhang X, Jiang L. | 01/5/2024 |
| Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression. | Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression.
Ma Y, Liu Y, Meng H., Free PMC Article | 11/18/2023 |
| PLAU contributes to the development of cholangiocarcinoma via activating NF-kappaB signaling pathway. | PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway.
Hu MD, Jia LH, Wang ML. | 07/17/2023 |
| Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCalpha-p38 MAPK pathway-mediated progression of human liver cancer cells. | Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells.
Ye JC, Hsieh YS, Chen PN, Liu JY, Hsieh YH. | 06/16/2023 |
| Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics. | Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics.
Kumar AA, Vine KL, Ranson M. | 06/15/2023 |
| m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability. | m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
Liu F, Xia F, Wang C, Ren R, Zhang M, Gong J, Zhang Q. | 04/26/2023 |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ, Uddin MN, Xu Z, Buckley BJ, Perera C, Pang TCY, Mekapogu AR, Moni MA, Notta F, Gallinger S, Pirola R, Wilson J, Ranson M, Goldstein D, Apte M., Free PMC Article | 01/14/2023 |
| PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer. | PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.
Gao Y, Ma X, Lu H, Xu P, Xu C., Free PMC Article | 12/31/2022 |
| METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner. | METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
Yu T, Liu J, Wang Y, Chen W, Liu Z, Zhu L, Zhu W. | 06/11/2022 |
| In situ hybridization for the assessment of urokinase plasminogen activator and plasminogen activator inhibitor type1 in formalinfixed paraffinembedded breast cancer specimens. | In situ hybridization for the assessment of urokinase plasminogen activator and plasminogen activator inhibitor type‑1 in formalin‑fixed paraffin‑embedded breast cancer specimens.
Boissière-Michot F, Mollevi C, Baecker V, Crapez E, Jacot W. | 05/7/2022 |
| Long non-coding RNA TRPM2-AS regulates microRNA miR-138-5p and PLAU (Plasminogen Activator, Urokinase) to promote the progression of gastric adenocarcinoma. | Long non-coding RNA TRPM2-AS regulates microRNA miR-138-5p and PLAU (Plasminogen Activator, Urokinase) to promote the progression of gastric adenocarcinoma.
Sun J, Zhou F, Xue J, Ji C, Qu Y, Pan Y., Free PMC Article | 02/19/2022 |
| Two Rare Variants in PLAU and BACE1 Genes-Do They Contribute to Semantic Dementia Clinical Phenotype? | Two Rare Variants in PLAU and BACE1 Genes-Do They Contribute to Semantic Dementia Clinical Phenotype?
Gaweda-Walerych K, Sitek EJ, Borczyk M, Berdyński M, Narożańska E, Brockhuis B, Korostyński M, Sławek J, Zekanowski C., Free PMC Article | 02/12/2022 |
| Roles of the Na(+)/H(+) Exchanger Isoform 1 and Urokinase in Prostate Cancer Cell Migration and Invasion. | Roles of the Na(+)/H(+) Exchanger Isoform 1 and Urokinase in Prostate Cancer Cell Migration and Invasion.
Li X, Buckley B, Stoletov K, Jing Y, Ranson M, Lewis JD, Kelso M, Fliegel L., Free PMC Article | 02/5/2022 |
| Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP. | Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y, Chen J, Li X, Luo M, Chen H, Cui B, Wang L, Lv D, Feng Y, Zhang P. | 01/15/2022 |
| The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation. | The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation.
Vorstandlechner V, Laggner M, Copic D, Klas K, Direder M, Chen Y, Golabi B, Haslik W, Radtke C, Tschachler E, Hötzenecker K, Ankersmit HJ, Mildner M., Free PMC Article | 12/4/2021 |
| uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils. | uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils.
Uhl B, A Mittmann L, Dominik J, Hennel R, Smiljanov B, Haring F, B Schaubächer J, Braun C, Padovan L, Pick R, Canis M, Schulz C, Mack M, Gutjahr E, Sinn P, Heil J, Steiger K, Kanse SM, Weichert W, Sperandio M, Lauber K, Krombach F, Reichel CA., Free PMC Article | 10/30/2021 |
| Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU). | Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
Wang Y, Zhu M, Li J, Xiong Y, Wang J, Jing H, Gu Y., Free PMC Article | 09/25/2021 |
| In Vitro Study of the Fibrinolytic Activity via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1. | In Vitro Study of the Fibrinolytic Activity via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1.
Gao C, Shen Q, Tang P, Cao Y, Lin H, Li B, Sun P, Bao B, Wu W., Free PMC Article | 05/15/2021 |
| Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors. | Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors.
Buckley BJ, Kumar A, Aboelela A, Bujaroski RS, Li X, Majed H, Fliegel L, Ranson M, Kelso MJ., Free PMC Article | 04/24/2021 |
| Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells. | Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.
Zhou L, Guo H, Jia F, Chen X, Zhang X, Dong S, Zhao L., Free PMC Article | 04/17/2021 |
| Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity. | Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity.
Sevillano N, Bohn MF, Zimanyi M, Chen Y, Petzold C, Gupta S, Ralston CY, Craik CS., Free PMC Article | 04/17/2021 |
| Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma. | Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
Semina EV, Rubina KA, Shmakova AA, Rysenkova KD, Klimovich PS, Aleksanrushkina NA, Sysoeva VY, Karagyaur MN, Tkachuk VA., Free PMC Article | 03/13/2021 |
| The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. | The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer.
Banys-Paluchowski M, Witzel I, Aktas B, Fasching PA, Hartkopf A, Janni W, Kasimir-Bauer S, Pantel K, Schön G, Rack B, Riethdorf S, Solomayer EF, Fehm T, Müller V., Free PMC Article | 09/19/2020 |
| Fluid shear stress stimulates breast cancer cells to display invasive and chemoresistant phenotypes while upregulating PLAU in a 3D bioreactor. | Fluid shear stress stimulates breast cancer cells to display invasive and chemoresistant phenotypes while upregulating PLAU in a 3D bioreactor.
Novak CM, Horst EN, Taylor CC, Liu CZ, Mehta G., Free PMC Article | 09/19/2020 |